Several experiments carried out by Oliphant suggested that the agent could be inactivated by ultraviolet light, but experiments by MacCallum et a.l. indicated that difficulties might. arise in determining the suitable energy to be used and the duration of exposure. In their first experiment the supposedly suitable. exposure failed to inactivate. In the second experiment the irradiation may have been effective, but when the serum was examined electrophoretically by Dr. R. A. Kekwick it was found that gross changes had occurred in the proteins. A very small residue of probably unchanged gamma globulin was detectable. Since the immune bodies in convalescent serum appear to be associated with the gamma globulin fraction this serum had been rendered useless for such a purpose. Even so, of the 10 recipients of this serum, one became jaundiced twenty-seven days after inoculation.
It has been suggested that very large pools would be safe because there would be sufficient immune bodies to neutralize any agent present. That such an event may occur has been shown by Oliphant, who inoculated a commercial pool of serum which contained serum of an individual taken four days before he became jaundiced (the total number of contributors to the pool was not stated). The jaundiced donor in this case was presumably suffering from infective hepatitis. This pool failed to produce hepatitis when injected subcutaneously or intravenously. Since the probability of neutralization occurring is unpredictable, this method does not seem safe. Though impracticable in wartime, the safest procedure would seem to be to process sera individually or at most small pools of two or three sera, thus limiting the number of recipients at risk if an icterogenic agent is present. If some idea could be obtained of the number of units of the agent that are neutralized by a given quantity of immune gamma globulin, the latter might be added to all pools as a routine.
SUMMARY
The available evidence suggests that the agent responsible for most cases of homologous serum hepatitis is not the same as that causing naturally occurring infective hepatitis.
The agent will pass through the usual filters which retain bacteria, but its actual size has not been determined. It is extremely resistant to heat and disinfectants, and no satisfactory method for the routine treatment of serum is known a present. BIBLIOGRAPHY BEESON, P. B., CIESNEY, G., and McFARLAN, A. M. (1944) Dr. H. E. Magee: Two Cases of Homologous Serum Jaundice. My remarks are concerned mainly with the history of two cases of homologous serum jaundice, treated with protein hydrolysates.
Intravenous alimentation with protein hydrolysates and glucose was used in the treatment of severe cases of starvation in Holland and in the German horror camps. The treatment was not a resounding success; it was also employed with a fair amount of success in the treatment of a few cases of advanced starvation in repatriated men from Germany in the spring and summer of 1945. I have already discussed the principles of treatment in a paper given to the Section of Medicine last year (Proc. R. Soc. Med., 38, 388) and again in the Milroy Lectures given in February (Brit. med. J., 1946 (i) 475) . After the arrival of the first case of starvation in England in 1945, the Ministry of Health established emergency supplies of hydrolysates ready for administration at Headquarters in Whitehall and in the Regional Offices throughout the country.
On September 18, 1945, Dr. ap Simon of Park Prewett Hospital telephoned me saying that he had a case which he thought might benefit from intravenous alimentation and he gave me a history of the case. At first I doubted whether it was suitable because our experience, small as it was, had been confined to cases of plain starvation, and it was for such cases that the very limited supplies of hydrolysates were intended. However, when Dr. ap Simon informed me that the prognosis was hopeless, that the patient was comatose and had not retain-ed any food for nearly a week, I asked my colleague, Dr. Adcock, to take a sufficient supply for the case straightaway to Park Prewett Hospital. The treatment was commenced the next day.
The Park Prewett case was an Army Officer, aged 36, who on June 29, 1945, sustained simple fractures of the femur and the maxilla and a flesh wound of the leg with severe shock. He was given 1 pint each of plasma and blood. Ten days later he was transferred to Park Prewett. He then had a mild attack of bronchopneumonia but soon recovered. During this time he had been visited by a patient who became jaundiced on September 7. On September 13, seventy-six days after transfusion, evidence of hepatitis began to show and became more and more grave during the next five days. On September 18, the patient vomited dark blood and became comatose. Glucose was given by vein and rectum. On September 19, he was deeply comatose and very cyanotic. Treatment with protein hydrolysate was begun (500 c.c., equivalent to 25 g. protein, 200 calories by vein preceded by 500 c.c. of 5% or 10% glucose, 200 to 400 calories by vein). The treatment was continued until September 24, the patient receiving a total of 3,500 c.c. hydrolysate (175 g. protein, 700 calories) and 350 g. glucose (1,400 calories). The injected veins thrombosed. Improvement set in on 22nd and on 24th he was able to take food by mouth, a low fat, high protein diet. By October 4 he was practically free of symptoms.
Convalescence was uneventful and he is now well.
A full report of this case was prepared by Dr. ap Simon and has since appeared in the Lancet (1946 (i) 492). I discussed the case subsequently with Dr. Bradley, and we arranged with Dr. Panton for the supplies of hydrolysates at Headquarters and in the Regions to be transferred to the Blood Transfusion Centres where a 24-hour service is in operation.
These supplies are therefore available at call in the Transfusion Centres.
The second case was a married woman, aged 30, under the care of Dr. Williams. On November 9, 1945, an ectopic pregnancy ruptured. At operation in Llanelly Hospital she was given two pints plasma and one pint of her own blood recovered from the abdomen. On November 26 she was discharged well. On January 7, 1946, fifty-eight days after transfusion symptoms of liver damage set in and increased in severity during the next four weeks. She was readmitted to Llanelly Hospital on February 8 but deteriorated so rapidly that Dr. Williams was convinced she would die. He asked Dr. Watkin, Cardiff Blood Transfusion Centre, to see her. Her condition was very grave but she was not comatose; nausea, vomiting and continuous salivation and jaundice were marked.
Dr. Watkin telephoned me on February 13, and I advised treatment with protein hydrolysate to begin at once, each dose to be preceded by 500 c.c. 5 or 10% glucose and to be given once or twice daily as he thought fit. I warned him of the likelihood of thrombosis and he gave 5,000 Toronto units of heparin before every infusion. Treatment began on February 14 when she was given by vein 400 c.c. 5-4% glucose followed by 500 c.c. hydrolysate twice. On each of 15th, 16th, 18th and 19th she was given 400 c.c. 10% glucose and 500 c.c. hydrolysate once. Improvement was apparent on 15th and by 20th she was able to take skimmed milk by mouth. Her appetite continued to imprpve but on 22nd it was decided to give more hydrolysate. During the infusion she had a severe rigor, vomited and then collapsed. She was given adrenaline and coramine and recovered after an hour. Improvement continued during the next three days, but soreness of the mouth, herpes and a scarlatiniform rash over the thrombosed sites of the venipunctures appeared on 25th and was general on 26th. On 27th the rash had gone and she was eating well, 1,400 to 1,600 calories a day. I saw her the next day and apart from slight jaundice and pain at the sites of injection she was quite well. Appetite and general condition improved until March 5, when she had a sudden flare-up of an old pyelitis which was practically over in forty-eight hours. By March 12 her appetite was very good and there was little jaundice. She has gone on improving and the last report I had, on March 21, said she was improving satisfactorily. During the six days of intravenous alimentation she received about 1,400 calories and the equivalent of 150 g. protein.
The Llanelly patient had many ups and downs. If only we knew the causes of the downs, it would enable us to have a better understanding of this condition and of how to treat it. Progress was not so satisfactory as in the Park Prewett case, but it should be noted that the latter received 3,500 c.c. hydrolysate in four days whereas the Llanelly case got 3,000 in six days. It may be that rapid administration from the start is the best mnethod of treatment. I should be inclined to recommend this in any future case. The set-back in the Llanelly case on February 22 and the subsequent rash suggested a protein reaction, but the manufacturers have assured us that the hydrolysate is free from protein and from long-chain polypeptides.
Whipple (Amer. J. med. Sci., 1946, 211, 149) , who has done much fundamental work on protein regeneration, has shown that the 10 essential amino-acids, plus glycine, can be given by vein, or intraperitoneally for days and weeks on end to human patients, as the main or even the sole nutriment, and positive nitrogen balances and increases in body-weight have resulted. According to him, the unnatural isomers of the amino-acids are not toxic to man, but aspartic acid and especially glutamic acid are toxic when administered by vein. Casein hydrolysates like those used for these cases are relatively rich in glutamic acid. It may be that the Llanelly case was unusually sensitive to glutamic acid. Beattie (Nature, 1944, 153, 525) has shown that methionine alone is useful prophylactically and therapeutically in liver damage from various causes. These digests are still in the experim-ental stage and more research requires to be done to bring them to the desired state of perfection. Nevertheless, there can be little doubt that the preparation used, with all its imperfections, has been mainly responsible for saving the lives of these two patients.
I have to thank Drs. ap Simon, Watkin and Williams and the Editor of th-e Lancet for their courtesy in permitting me to discuss these cases.
Professor John Beattie: The available evidence points to the conclusion that homologous serum jaundice is an infectious disease caused by an agent probably of a virus nature.
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My group has been concerned with a study of the physiological and biochemical phenomena which appear during the acute and recovery phases of the disease. The disease is essentially an hepatic condition in which there are varying degrees of dysfunction and of destruction of hepatic tissue. In animals Mann has shown that signs of hepatic insufficiency do not appear until the total mass of the liver is reduced to around 20% of its normal value. If we can apply this conclusion to the disease we are studying it would appear that more than 80% of the liver may be thrown out of action-either because of disturbed function or anatomical destruction-during the acute phase of the disease. If hepatic tissue can be destroyed or rendered afunctional, to the extent suggested by Mann's experiments, before clinical and biochemical signs of hepatic insufficiency appear, it is obvious that the disease has taken hold and is progressing for some time before the critical level of insufficiency is reached.
There are some pieces of evidence which suggest that this may happen. In suspected cases of the disease admitted to hospital because of vague abdominal discomfort and slight hepatic enlargement and which later developed all the characteristic signs and symptoms, it was found on admission that a considerable loss of body-weight had already occurred varying from 2 to 10 kg., although anorexia had not developed to a degree sufficient to account for the weight loss. Nitrogen balance experiments demonstrated a marked negative nitrogen balance. The conclusion which we came to was that even before any clinical signs or symptoms-even the vaguesthad appeared, there was either an excessive destruction of body protein or alternatively that the rate of protein synthesis within the body had been reduced considerably below the normal rate of protein destruction. This state of negative nitrogen balance persisted during the acute phase of the disease and became positive with the return of appetite and other signs of clinical improvement. The positive balance was, however, due not to a reduction in the urinary nitrogen, but to an increase in nitrogen input. The rate at which the body-weight increased during the phase of positive nitrogen balance could be predicted with some degree of accuracy from the magnitude of the positive balance.
If we accept the hypothesis that homologous serum jaundice is a virus disease, we can interpret our findings along these lines. During the so-called incubation period of the disease, the virus protein is multiplying and obtaining the various specific amino-acids, which it requires to build its molecule, from the protein matrix of the body cells. If a sufficient number -of liver cells are invaded by the virus, then a time will come when the liver cell cannot supply sufficient new protein for the general body needs. At that time and for some time before it the body must be in a state of negative nitrogen balance and protein requirements of the body must be met from the protein reserves in the tissues. Consequently weight must be lost. We can envisage this phase being completed without any clinical disturbance. When the virus continues to grow within the hepatic cell, a time will come when the virus will grow at the expense of the essential proteins of the cell itself and consequently necrosis takes place. The onset of clinical symptoms will date from the time when a sufficient number of liver cells are destroyed and a sufficient number rendered afunctional because of the presence of a large amount of virus body. If the process of virus growth is unchecked, the complete destruction of all the hepatic tissue takes place.
In the great majority of cases, the disease is checked, sometimes before icteric staining appears and sometimes only after a large portion of the liver tissue is destroyed. We may presume that the checking of the disease is due to the production of some specific antibody which is most likely to be of a protein nature. If this interpretation is correct, we can see that the nutritional state of the individual is a matter of some importance in determining the severity of the disease. When the protein reserves of the body are large, there will be more time for antibody to be produced before necrosis of the hepatic tissue reaches a critical level.
It must be emphasized here that this interpretation, while it does seem to fit the facts we have determined, cannot be considered as other than a tentative explanation.
We observed in severe or moderately severe cases material clinical benefit to follow the administration of large doses of methionine. In the less severe cases this benefit was not apparent to such a striking degree. We might therefore ask the question: How does methionine produce a clinical improvement? It is obvious that it cannot within a matter of a few hours or days produce a rapid regeneration of hepatic tissue. Al, present we incline to the view that methionine may effect clinical improvement in some part by its lipotropic action. The cells which are in process of necrosis around the intralobular virus are surrounded by a ring of cells packed with fat globules. Hence the cells are swollen and produce a mechanical obstructiQn to the free flow of blood to the centre of the lobule and also obstruct to some degree the bile capillaries. When methionine is given, fat is moved rapidly out of the hepatic cells and into the blood-stream. As this occurs, there is some degree of ketosis and ketone bodies apnear in the urine. The final result is a rapid shrinkage of the liver and a fall in the serum bilirubin values. Nausea and vomiting, if present, disappear and there is a return of appetite.
In all probability this explanation is incomplete but it does exDlain why methionine is most effective when the liver is markedly enlarged and least effective when the liver is small, i.e. when necrosis is already extensive.
From the epidemiological point of view we came to the conclusion that both in this disease and in infective hepatitis, the patient was infectious for an unknown period before the onset of the first clinical symptoms. During this phase, the disease was already well established but symptoms had not appeared because (1) hepatic dysfunction and destruction had not proceeded to the stage where hepatic insufficiency developed, and (2) intrahepatic obstruction due to fat deposition had not occurred.
